Clinical Trial Update: Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing topical bromfenac to placebo for safety and efficacy in reducing ocular inflammation after cataract surgery. The study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• BROMFENAC (Bromfenac)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Postoperative Complications, Cataract | Phase 3 | Status: COMPLETED